1. Academic Validation
  2. TWEAK attenuates the transition from innate to adaptive immunity

TWEAK attenuates the transition from innate to adaptive immunity

  • Cell. 2005 Dec 2;123(5):931-44. doi: 10.1016/j.cell.2005.09.022.
Heather Maecker 1 Eugene Varfolomeev Frank Kischkel David Lawrence Heidi LeBlanc Wyne Lee Stephen Hurst Dimitry Danilenko Jun Li Ellen Filvaroff Becky Yang Dylan Daniel Avi Ashkenazi
Affiliations

Affiliation

  • 1 Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Abstract

Innate immunity is the first line of defense against Infection, protecting the host during the development of adaptive immunity and critically affecting the nature of the adaptive response. We show that, in contrast to tumor necrosis factor alpha (TNF-alpha), the related protein TWEAK attenuates the transition from innate to adaptive mechanisms. TWEAK-/- mice had overabundant natural killer (NK) cells and displayed hypersensitivity to Bacterial endotoxin, with their innate immune cells producing excess interferon (IFN)-gamma and interleukin (IL)-12. TWEAK inhibited stimulation of the transcriptional activator STAT-1 and induced p65 nuclear factor (NF)-kappaB association with histone deacetylase 1, repressing cytokine production. TWEAK-/- mice developed oversized spleens with expanded memory and T helper 1 (TH1) subtype cells upon aging and mounted stronger innate and adaptive TH1-based responses against tumor challenge. Thus, TWEAK suppresses production of IFN-gamma and IL-12, curtailing the innate response and its transition to adaptive TH1 immunity.

Figures
Products